{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:25:47Z","timestamp":1779416747448,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA 0530303"],"award-info":[{"award-number":["XDA 0530303"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013152","name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373708"],"award-info":[{"award-number":["82373708"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22171275"],"award-info":[{"award-number":["22171275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.apsb.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:39:39Z","timestamp":1770424779000},"page":"3157-3174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel entry inhibitor targeting the stalk domain of the hemagglutinin of H1N1"],"prefix":"10.1016","volume":"16","author":[{"given":"Ying","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-7655","authenticated-orcid":false,"given":"Weibo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2177-3259","authenticated-orcid":false,"given":"Xiankun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.02.003_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/vaccines12020173","article-title":"Effectiveness of influenza vaccination and early antiviral treatment in reducing pneumonia risk in severe influenza cases","volume":"12","author":"Godoy","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.apsb.2026.02.003_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00040-22","article-title":"Antiviral approaches against influenza virus","volume":"36","author":"Kumari","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.apsb.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.32607\/actanaturae.11020","article-title":"Efficacy of (R)-6-adamantane-derivatives of 1,3-oxazinan-2-one and piperidine-2,4-dione in the treatment of mice infected by the A\/California\/04\/2009 influenza virus","volume":"13","author":"Glubokova","year":"2021","journal-title":"Acta Naturae"},{"key":"10.1016\/j.apsb.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/jvi.67.9.5585-5594.1993","article-title":"Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block","volume":"67","author":"Wang","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.str.2011.09.003","article-title":"Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses","volume":"19","author":"Pielak","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/303035a0","article-title":"Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution","volume":"303","author":"Varghese","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1098\/rstb.2001.1021","article-title":"Zanamivir: from drug design to the clinic","volume":"356","author":"Elliott","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.apsb.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1055\/s-0041-1733830","article-title":"Antiviral treatments for influenza","volume":"42","author":"Palomba","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.apsb.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1099\/0022-1317-33-1-159","article-title":"Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action","volume":"33","author":"Palese","year":"1976","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ph15010028","article-title":"Baloxavir marboxil: an original new drug against influenza","volume":"15","author":"Dufrasne","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1039\/D3MD00513E","article-title":"Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery","volume":"15","author":"Jia","year":"2024","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.apsb.2026.02.003_bib12","first-page":"153","article-title":"Influenza A: understanding the viral life cycle","volume":"82","author":"Samji","year":"2009","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.apsb.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1099\/vir.0.051136-0","article-title":"Insight into structural diversity of influenza virus haemagglutinin","volume":"94","author":"Cho","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2174\/0929867322666150227153919","article-title":"Inhibitors targeting the influenza virus hemagglutinin","volume":"22","author":"Li","year":"2015","journal-title":"Curr Med Chem"},{"issue":"Suppl 2","key":"10.1016\/j.apsb.2026.02.003_bib16","first-page":"S149","article-title":"Novel hemagglutinin-based influenza virus inhibitors","volume":"5","author":"Shen","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.apsb.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/v5010352","article-title":"Influenza A virus entry inhibitors targeting the hemagglutinin","volume":"5","author":"Yang","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tim.2018.03.005","article-title":"Influenza hemagglutinin protein stability, activation, and pandemic risk","volume":"26","author":"Russell","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.apsb.2026.02.003_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038638","article-title":"Hemagglutinin structure and activities","volume":"11","author":"Gamblin","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.apsb.2026.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104782","article-title":"Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus","volume":"177","author":"Hussein","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2026.02.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105013","article-title":"Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins","volume":"186","author":"Du","year":"2021","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1016\/j.apsb.2023.08.010","article-title":"Emerging drug design strategies in anti-influenza drug discovery","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.chempr.2022.10.019","article-title":"Multicomponent coupling and macrocyclization enabled by Rh(III)-catalyzed dual C\u2013H activation: macrocyclic oxime inhibitor of influenza H1N1","volume":"9","author":"Wang","year":"2023","journal-title":"Chem"},{"key":"10.1016\/j.apsb.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.79.18.11705-11715.2005","article-title":"Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication","volume":"79","author":"Suzuki","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/ml2000627","article-title":"Design and synthesis of benzenesulfonamide derivatives as potent anti-influenza hemagglutinin inhibitors","volume":"2","author":"Tang","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jmv.25013","article-title":"Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015","volume":"90","author":"Tandel","year":"2018","journal-title":"J Med Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"Comment on the paper: a three-dimensional model to analyze drug\u2012drug interactions: Prichard, M.N. and Shipman, C., Jr.","volume":"14","author":"S\u00fchnel","year":"1990","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2026.02.003_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.apsb.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1002\/jmv.27870","article-title":"Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic","volume":"94","author":"Zhang","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and antiviral resistance: an overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.apsb.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1039\/C4SC03089C","article-title":"Macrocycles: lessons from the distant past, recent developments, and future directions","volume":"6","author":"Yudin","year":"2015","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13020-023-00843-4","article-title":"A potential Chinese medicine monomer against influenza A virus and influenza B virus: isoquercitrin","volume":"18","author":"Luo","year":"2023","journal-title":"Chin Med"},{"key":"10.1016\/j.apsb.2026.02.003_bib33","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001593","article-title":"Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells","volume":"102","author":"Dissanayake","year":"2021","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009480","article-title":"Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration","volume":"17","author":"Cresta","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.apsb.2026.02.003_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1338802","article-title":"Aluminium phthalocyanine-mediated photodynamic therapy induces ATM-related DNA damage response and apoptosis in human oesophageal cancer cells","volume":"14","author":"Didamson","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2026.02.003_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114608","article-title":"Discovery of potent ebola entry inhibitors with (3S,4aS,8aS)2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold","volume":"240","author":"Han","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1021\/acs.jmedchem.4c00319","article-title":"Modular biomimetic strategy enables discovery and SAR exploration of oxime macrocycles as influenza A virus (H1N1) inhibitors","volume":"67","author":"Xu","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.02.003_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00878-19","article-title":"Novel small molecule targeting the hemagglutinin stalk of influenza viruses","volume":"93","author":"Kim","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug\u2012drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"eaar6221","DOI":"10.1126\/science.aar6221","article-title":"A small-molecule fusion inhibitor of influenza virus is orally active in mice","volume":"363","author":"Van Dongen","year":"2019","journal-title":"Science"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:45:33Z","timestamp":1779414333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2211383526001036"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.02.003","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel entry inhibitor targeting the stalk domain of the hemagglutinin of H1N1","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}